ResMed Inc. (RMD)

ResMed Inc. (RMD) is a healthcare company (medical instruments & supplies) based in the United States. The share price is $238.90, up 0.30% on the day, which values the company at $33.6B. Price as of 17 Nov 2026, 17:16 UTC, from Yahoo Finance.

Key facts

Share price
$238.90+0.30% today
Market value
$33.6B
P/E ratio
21.8×last 12 months
Forward P/E
18.1×
Dividend yield
1.03%
Funk Score
86/100
Against its own history
About its usual priceusual price $261.06
200-week average
$220.568% above

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

ResMed Inc. in more detail

RMD trades at 21.8× its last twelve months' earnings, 18.1× next year's expected earnings, 5.9× sales. Measured against its own history, the price is 8% below what its usual multiples would imply ($261.06) — about its usual price. It sits 8% above its 200-week average of $220.56.

Over the last five fiscal years ResMed Inc. has compounded revenue 12.1% a year, earnings per share 26.3% a year, free cash flow 20.8% a year. Its Funk Score is 86 out of 100 (financial strength 9.4, profitability 10.0, growth 8.4, value 6.7, each out of 10).

In its favour: Altman Z in the safe zone; Strong Piotroski score.

1 of the superinvestors tracked here hold RMD, including François Rochon (2.8% of the portfolio).

Superinvestors holding RMD

1 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:RMD vs ZTS (ResMed Inc. vs Zoetis)RMD vs ILMN (ResMed Inc. vs Illumina)RMD vs GMAB (ResMed Inc. vs Genmab)RMD vs CNC (ResMed Inc. vs Centene)RMD vs MTD (ResMed Inc. vs Mettler-Toledo International)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

ResMed Inc. (RMD): questions and answers

What is RMD's P/E ratio?

ResMed Inc. trades at 21.8× its last twelve months' earnings and 18.1× next year's expected earnings. At its fiscal year-ends over the past 17 years the P/E ranged from 18.2× to 76.1×, with a median of 25.4×.

What is RMD's PEG ratio?

ResMed Inc.'s PEG ratio is 1.28 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is ResMed Inc.'s market cap?

ResMed Inc. is valued at $33.6B at a share price of $238.90.

Is RMD overvalued or undervalued?

Against its own history, RMD is about its usual price: the price is 8% below the $261.06 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is RMD above its 200-week moving average?

Yes. RMD is 8.3% above its 200-week average of $220.56. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is ResMed Inc. growing?

Over the last five fiscal years ResMed Inc.'s revenue grew 12.1% a year and its earnings per share 26.3% a year; over ten years revenue grew 11.9% a year.

Cite this page

Funkfolio, “ResMed Inc. (RMD) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/RMD

Underlying data: Yahoo Finance; company filings with the SEC.